VRNA - Verona Pharma Insider Trades Send a Signal | Benzinga
David R Ebsworth, Director at Verona Pharma (NASDAQ:VRNA), reported a large insider buy on November 8, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Ebsworth purchased 160,000 shares of Verona Pharma. The total transaction amounted to $316,080.
Verona Pharma shares are trading up 2.06% at $14.4 at the time of this writing on Thursday morning.
Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.
The Importance of Insider Transactions
Insider transactions shouldn't be used primarily to make an investing decision, however, ...